Retinoic acid for treatment of multicentric Castleman's disease
- 9 October 1999
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 354 (9186), 1262-1263
- https://doi.org/10.1016/s0140-6736(99)03957-4
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Remission after 13-cis retinoic acid in thrombotic thrombocytopenic purpuraThe Lancet, 1998
- Retinoid Antagonism of NF-IL6: Insight into the Mechanism of Antiproliferative Effects of Retinoids in Kaposi’s SarcomaMolecular and Cellular Biology, 1997
- All‐trans‐retinoic acid in poems syndrome. Therapeutic effect associated with decreased circulating levels of proinflammatory cytokinesArthritis & Rheumatism, 1996
- Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpuraPediatric Nephrology, 1995
- Alleviation of Systemic Manifestations of Castleman's Disease by Monoclonal Anti-Interleukin-6 AntibodyNew England Journal of Medicine, 1994